Narrow vs wide surgery for invasive skin melanoma
Part of Cancer, Skin clinical trials.
This trial compares two surgeries for invasive melanoma: a narrow removal versus a wider one. It aims to see if a smaller surgery works as well, which could mean less scarring and recovery time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older
- You have a confirmed invasive melanoma on your skin (including on palms, soles, or under nails)
- Your melanoma is stage IA with certain risk features or stage IB
- A special test (Merlin Assay) shows your melanoma is low risk
- You haven't already had a wide excision or lymph node surgery for this melanoma
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study helps doctors decide the safest surgical approach for melanoma and similar skin tumors in children and young adults by using pathology reports and genetic information. The goal is to avoid unnecessary surgery while ensuring the best outcomes.
This trial studies whether removing a slightly wider strip of skin around a melanoma improves outcomes compared with a narrower strip. It also uses a lymph node staging procedure to check spread and helps doctors fine-tune surgery for stage II melanoma.
This trial compares having one surgery to remove extra skin around a thin melanoma versus the standard two-step approach (biopsy first, then a wider excision later). It aims to see if one surgery is just as safe and reduces the number of procedures.
This trial tests two methods of checking removed melanoma tissue to see which gives clearer results. It may help improve how doctors determine if all cancer was removed.
This trial compares less invasive procedures with the current standard treatment for early-stage melanoma in adults 75 and older. The goal is to find out if these less invasive options work just as well and help patients recover better.
This study tests whether patients with moderate-thickness skin melanoma need additional surgery after their initial tumor removal, or if careful monitoring alone is enough. The goal is to avoid unnecessary surgery while keeping patients safe.
Hear when a new Clinical Stage IA Cutaneous Melanoma AJCC v8 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.